Biodesix Inc. (BDSX) Tops Q2 EPS by 7c
Get Alerts BDSX Hot Sheet
Join SI Premium – FREE
Biodesix Inc. (NASDAQ: BDSX) reported Q2 EPS of ($0.40), $0.07 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $7.3 million versus the consensus estimate of $8.83 million.
GUIDANCE:
Biodesix Inc. sees FY2022 revenue of $37.5-39.5 million, versus the consensus of $38.4 million.
For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel on FedEx Freight (FDXF): 'Enters Its Post-Breakup Era - Time to Hit the Gym and Focus on Itself'
- Sensient Technologies (SXT) Tops Q3 EPS by 4c, Misses on Revenue; Offers FY26 EPS Guidance
- Forum Energy Technologies (FET) Tops Q3 EPS by 29c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share